Monopar Therapeutics (MNPR) said Wednesday it closed its best efforts public offering of common shares at $16.25 per share for total gross proceeds of about $19.2 million.
The company said it plans to use proceeds for general corporate purposes.
Monopar Therapeutics shares were down more than 6% in recent trading.
Price: 15.19, Change: -1.02, Percent Change: -6.29
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments